ARCHIVES

FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 13 | March 30, 2001

Download PDF Visit The Full Archive

Related Articles

Response From Center Representatives In L.A. To NCI Questions Is “Frusterating,” DeVita Says

April 13, 1984

In the States: Michigan to Allocate $50 Million Annually To Life Sciences

July 23, 1999

Special Report: Politicla Pressure, System Loopholes, Enabled Burzynski To Avoid Usuals

September 25, 1998

NIOSH To Fund 21 Projects With NCI Money

February 25, 1977

DCPC Advisors Approve Five New RFA concepts, Set Aside $33.6 Million

June 4, 1993

Pragmatists vs. Purists: Colon Cancer Screening Guideline Triggers Debate.

October 10, 2008